Stay updated on PD-L1+ NSCLC Camrelizumab + Famitinib Clinical Trial

Sign up to get notified when there's something new on the PD-L1+ NSCLC Camrelizumab + Famitinib Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the PD-L1+ NSCLC Camrelizumab + Famitinib Clinical Trial page

  1. Check
    today
    Change Detected
    Summary
    The web page has been updated from version 2.16.10 to version 2.16.11.
    Difference
    0.3%
    Check dated 2025-08-09T23:59:44.000Z thumbnail image
  2. Check
    8 days ago
    Change Detected
    Summary
    The web page has been updated to version 2.16.10, and a previous service alert regarding planned maintenance has been removed.
    Difference
    4%
    Check dated 2025-08-02T18:19:45.000Z thumbnail image
  3. Check
    15 days ago
    Change Detected
    Summary
    The web page has been updated to reflect a new version, changing from Revision v2.16.6 to v2.16.8, and it now includes information about HHS Vulnerability Disclosure.
    Difference
    0.8%
    Check dated 2025-07-26T14:26:43.000Z thumbnail image
  4. Check
    22 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.16.5 to version 2.16.6.
    Difference
    0.3%
    Check dated 2025-07-19T11:20:43.000Z thumbnail image
  5. Check
    29 days ago
    Change Detected
    Summary
    A service alert has been added indicating planned maintenance starting July 25th, during which most services will be unavailable for over 24 hours.
    Difference
    4%
    Check dated 2025-07-12T07:35:48.000Z thumbnail image
  6. Check
    36 days ago
    Change Detected
    Summary
    The page has been updated to version v2.16.5, and the previous version v2.16.4 has been removed from the content. Additionally, a significant note regarding the modernization of ClinicalTrials.gov data ingest scheduled for July 2025 has been deleted.
    Difference
    4%
    Check dated 2025-07-05T02:48:40.000Z thumbnail image

Stay in the know with updates to PD-L1+ NSCLC Camrelizumab + Famitinib Clinical Trial

Enter your email address, and we'll notify you when there's something new on the PD-L1+ NSCLC Camrelizumab + Famitinib Clinical Trial page.